US EditionPublished • loading... • Updated
FDA Indicates Reports of Ozempic Problems, Deaths Not Adequately Reported by Novo Nordisk
Summary by aboutlawsuits.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
FDA Indicates Reports of Ozempic Problems, Deaths Not Adequately Reported by Novo Nordisk
Inspectors say the company failed to report certain incidents it unilaterally determined were not the result of Ozempic side effects, but the FDA says federal regulations do not allow manufacturers to make that decision. Federal investigators say an inspection of Novo Nordisk facilities uncovered unreported incidents involving deaths and other problems on Oze…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
